EAU Guidelines on laser technologies

Česká verzia

Authors: T. R. W. Herrmann ¹; E. N. Liatsikos ²; U. Nagele ³; O. Traxer ⁴; A. S. Merseburger ¹
Authors place of work: Department of Urology and Urooncology, Medical School of Hannover, Hannover, Germany ¹; Department of Urology, University Hospital of Patras, Patras, Greece ²; Department of Urology and Andrology Bezirkskrankenhaus Hall, Hall in Tirol Austria ³; Department of Urology, Hospital Tenon, Paris, France ⁴
Published in the journal: Urol List 2012; 10(3): 73-86
Category: Guidelines

Summary

Context:
The European Association of Urology (EAU) Guidelines Office has set up a guideline working panel to analyse the scientific evidence published in the world literature on lasers in urologic practice.

Objective:
Review the physical background and physiologic and technical aspects of the use of lasers in urology, as well as current clinical results from these new and evolving technologies, together with recommendations for the application of lasers in urology. The primary objective of this structured presentation of the current evidence base in this area is to assist clinicians in making informed choices regarding the use of lasers in their practice.

Evidence acquisition:
Structured literature searches using an expert consultant were designed for each section of this document. Searches were carried out in the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and Medline and Embase on the Dialog/DataStar platform. The controlled terminology of the respective databases was used, and both Medical Subject Headings and EMTREE were analysed for relevant entry terms. One Cochrane review was identified.

Evidence synthesis:
Depending on the date of publication, the evidence for different laser treatments is heterogeneous. The available evidence allows treatments to be classified as safe alternatives for the treatment of bladder outlet obstruction in different clinical scenarios, such as refractory urinary retention, anticoagulation, and antiplatelet medication. Laser treatment for bladder cancer should only be used in a clinical trial setting or for patients who are not suitable for conventional treatment due to comorbidities or other complications. For the treatment of urinary stones and retrograde endoureterotomy, lasers provide a standard tool to augment the endourologic procedure.

Conclusions:
In benign prostatic obstruction (BPO), laser vaporisation, resection, or enucleation are alternative treatment options. The standard treatment for BPO remains transurethral resection of the prostate for small to moderate size prostates and open prostatectomy for large prostates. Laser energy is an optimal treatment method for disintegrating urinary stones. The use of lasers to treat bladder tumours and in laparoscopy remains investigational.

Key words:
BPH, BPO, BPE, laser therapy, KTP PVP, LBO PVP, TURP, TUR, Ho:YAG, Tm:YAG, prostate cancer, bladder cancer, nephrectomy, endoscopy, laparoscopy, endoureterectomy, UPJ obstruction, UUT, stones, photoselective vaporisation, EAU Guidelines

Zdroje

1. Herrmann TRW, Nagele U, Traxer O, Merseburger AS. EAU guidelines on lasers and technologies. Arnhem, the Netherlands: European Association of Urology; 2011.

2. Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004, CD001987.

3. Reich O, Gratzke C, Bachmann A et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180(1): 246–249.

4. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl- phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998; 51(2): 254–256.

5. Bouchier-Hayes DM, Anderson P, Van Appledorn S et al. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20(8): 580–585.

6. Horasanli K, Silay MS, Altay B et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008; 71(2): 247–251.

7. Tasci AI, Tugcu V, Sahin S et al. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22(2): 347–353.

8. Skolarikos A, Papachristou C, Athanasiadis G et al. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol 2008; 22(10): 2333–2340.

9. Pfitzenmaier J, Gilfrich C, Pritsch M et al. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm- results and comparison with prostates of <80 mL. BJU Int 2008; 102(3): 322–327.

10. Al-Ansari A, Younes N, Sampige VP et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010; 58(3): 349–355.

11. Rajbabu K, Chandrasekara SK, Barber NJ et al. Photoselective vaporization of the prostate with the potassiumtitanyl- phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100(3): 593–598.

12. Ruszat R, Wyler S, Forster T et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51(4): 1031–1041.

13. Ruszat R, Seitz M, Wyler SF et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54(4): 893–901.

14. Tugcu V, Tasci AI, Sahin S et al. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22(7): 1519–1525.

15. Ruszat R, Wyler S, Seifert H-H et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol 2006; 50(5): 1040–1049.

16. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009; 73(4): 807–810.

17. Te AE, Malloy TR, Stein BS et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97(6): 1229–1233.

18. Choi B, Tabatabaei S, Bachmann A et al. GreenLight HPS 120-W laser for benign prostatic hyperplasia: comparative complications and technical recommendations. Eur Urol Suppl 2008; 7: 384–392.

19. Bruye’re F, Puichaud A, Pereira H et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010; 58(2): 207–211.

20. Kavoussi PK, Hermans MR. Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med 2008; 5(11): 2669–2671.

21. Chen CH, Chiang PH, Chuang YC et al. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 2010; 75(3): 658–663.

22. Erol A, Cam K, Tekin A et al. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 2009; 182: 1078–1082.

23. Rieken M, Kang HW, Koullick E et al. Laser vaporization of the prostate in vivo: experience with the 150-W 980-nm diode laser in living canines. Lasers Surg Med 2010; 42(8): 736–742.

24. Chiang PH, Chen CH, Kang CH et al. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 2010; 42(7): 624–629.

25. Ruszat R, Seitz M, Wyler SF et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009; 104(6): 820–825.

26. Rieken M, Wyler S, Muller G et al. Laser vaporization of the prostate: intermediate-term follow-up with the 200Whigh-intensity diode (HiDi) laser system [abstract 589]. Eur Urol Suppl 2009;8:269.

27. Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol 2007; 25(3): 221–225.

28. Mottet N, Anidjar M, Bourdon O et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999; 13(2): 127–130.

29. Elmansy HM, Elzayat E, Elhilali MM. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. J Urol 2010; 184(5): 2023–2028.

30. Kabalin JN, Mackey MJ, Cresswell MD et al. Holmium: YAG laser resection of prostate (HoLRP) for patients in urinary retention. J Endourol 1997; 11(4): 291–293.

31. Westenberg A, Gilling P, Kennett K et al. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004; 172(2): 616–619.

32. Fraundorfer MR, Gilling PJ. Holmium: YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998; 33(1): 69–72.

33. Hochreiter WW, Thalmann GN, Burkhard FC et al. Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002; 168 (4 Pt 1): 1470–1474.

34. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol 2004; 18(2): 189–191.

35. Kuntz RM, Ahyai S, Lehrich K et al. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172(3): 1012–1016.

36. Briganti A, Naspro R, Gallina A et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006; 175(5): 1817–1821.

37. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int 2006; 97(1): 85–89.

38. Naspro R, Suardi N, Salonia A et al. Holmium laser enucleation of the prostate versus open prostatec-tomy for prostates >70 g: 24- month follow-up. Eur Urol 2006; 50(3): 563–568.

39. Wilson LC, Gilling PJ, Williams A et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006; 50(3): 569–573.

40. Montorsi FNR, Salonia A, Suardi N et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2008; 179 (5 Suppl): S87–90.

41. Gilling PJ, Aho TF, Frampton CM et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 2008; 53(4): 744–749.

42. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 2008; 53(1): 160–168.

43. Lourenco T, Pickard R, Vale L et al. Benign Prostatic Enlargement team. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomized controlled trials. BMJ 2008; 337: a449.

44. Tan A, Liao C, Mo Z et al. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 2007; 94(10): 1201–1208.

45. Bach T, Netsch C, Haecker A et al. Thulium: YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 2010; 28(1): 39–43.

46. Bach T, Xia S, Yang Y et al. Thulium:YAG 2 mm cw laser prostatectomy: where do we stand? World J Urol 2010; 28(2): 163–168.

47. Mattioli S, Munoz R, Recasens R et al. Treatment of benign prostatic hyperplasia with the Revolix laser [in Spanish]. Arch Esp Urol 2008; 61(9): 1037–1043.

48. Xia S-J, Zhuo J, Sun X-W et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53(2): 382–390.

49. Fu WJ, Zhang X, Yang Y et al. Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1- year follow-up. Urology 2010; 75(1): 194–199.

50. Bach T, Netsch C, Haecker A et al. Thulium: YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 2010; 28(1): 39–43.

51. Bach T, Herrmann TRW, Haecker A et al. Thulium: yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 2009; 104(3): 361–364.

52. Bach T, Herrmann TR, Ganzer R et al. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 2007; 25(3): 257–262.

53. Bach T, Herrmann TR, Ganzer R et al. [Thulium:YAG vaporesection of the prostate. First results [in German]. Urologe A 2009; 48(5): 529–534.

54. Shao Q, Zhang FB, Shang DH et al. Comparison of holmium and thulium laser in transurethral enucleation of the prostate [in Chinese]. Zhonghua Nan Ke Xue 2009; 15(4): 346–349.

55. Bach T, Netsch C, Pohlmann L et al. Thulium: YAG vapoenucleation in large volume prostates. J Urol 2011; 186(6): 2323–2327.

56. Bach T, Wendt-Nordahl G, Michel MS et al. Feasibility and efficacy of thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 2009; 27(4): 541–545.

57. Bach T, Herrmann TRW, Netsch C et al. 1917 Vapoenucleation of the prostate using the thulium:YAG 2 Micron CW Laser in high-risk patients. J Urol 2010; 183 (4 Suppl 1): e745–746.

58. Fu WJ, Hong BF, Yang Y et al. Vaporesection for managing benign prostatic hyperplasia using a 2 microm continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int 2009; 103(3): 352–356.

59. Herrmann TR, Bach T, Imkamp F et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 2010; 28(1): 45–51.

60. Staehler G, Schmiedt E, Hofstetter A. Destruction of bladder neoplasms by means of transurethral neodym-YAG-laser coagulation [in German]. Helv Chir Acta 1978; 45(3): 307–311.

61. Saito S. Transurethral en bloc resection of bladder tumors. J Urol 2001; 166(6): 2148–2150.

62. Das A, Gilling P, Fraundorfer M. Holmium laser resection of bladder tumors (HoLRBT). Tech Urol 1998; 4(1): 12–14.

63. Soler-Martinez J, Vozmediano-Chicharro R, Morales-Jimenez P et al. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. J Urol 2007; 178(6): 2337–2339.

64. Zhu Y, Jiang X, Zhang J et al. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 2008; 72(3): 608–612.

65. Xishuang S, Deyong Y, Xiangyu C et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 2010; 24(1): 69–73.

66. Zhong C, Guo S, Tang Y et al. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: singlecenter experience. World J Urol 2010; 28(2): 157–161.

67. Gao X, Ren S, Xu C et al. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int 2008; 102(9): 1115–1118.

68. Yang Y, Wei ZT, Zhang X et al. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol 2009; 182(1): 66–69.

69. Barzilay B, Lijovetzky G, Shapiro A et al. The clinical use of CO2 laser beam in the surgery of kidney parenchyma. Lasers Surg Med 1982; 2(1): 81–87.

70. Hodgson DK, Rajbabu K, Graziano M et al. Appraisal of a novel procedure: potassium titanyl phosphate (KTP) laser laparoscopic partial nephrectomy. J Endourol 2008; 22: 159–212.

71. Gruschwitz T, Stein R, Schubert J et al. Laser-supported partial nephrectomy for renal cell carcinoma. Urology 2008; 71(2): 334–336.

72. Korhonen AK, Talja M, Karlsson H et al. Contact Nd: YAG laser and regional renal hypothermia in partial nephrectomy. Ann Chir Gynaecol Suppl 1993; 206: 59–62.

73. Lotan Y, Gettman MT, Ogan K et al. Clinical use of the holmium:YAG laser in laparoscopic partial nephrectomy. J Endourol 2002; 16(5): 289–292.

74. Malloy TR, Schultz RE, Wein AJ et al. Renal preservation utilizing neodymium:YAG laser. Urology 1986; 27(2): 99–103.

75. Merguerian PA, Seremetis G. Laser-assisted partial nephrectomy in children. J Pediatr Surg 1994; 29(7): 934–936.

76. Rosemberg SK. Clinical experience with carbon dioxide laser in renal surgery. Urology 1985; 25(2): 115–118.

77. Gianduzzo TR, Chang CM, El-Shazly M et al. Laser nerve-sparing laparoscopic radical prostatectomy: a feasibility study. BJU Int 2007; 99(4): 875–879.

78. Lovisolo JA, Legramandi CP, Fonte A. Thermal ablation of small renal tumors—present status. ScientificWorldJournal 2007; 7: 756–767.

79. Singal RK, Denstedt JD, Razvi HA et al. Holmium: YAG laser endoureterotomy for treatment of ureteral stricture. Urology 1997; 50(6): 875–880.

80. Corcoran AT, Smaldone MC, Ricchiuti DD et al. Management of benign ureteral strictures in the endoscopic era. J Endourol 2009; 23(11): 1909–1912.

81. Fu YM, Ni SB, Chen QY et al. Treatment of ureteral obstruction by holmium:YAG laser endoureterotomy: a report of 18 cases [in Chinese]. Zhonghua Yi Xue Za Zhi 2009; 89(5): 335–337.

82. Gdor Y, Gabr AH, Faerber GJ et al. Success of laser endoureterotomy of ureteral strictures associated with ureteral stones is related to stone impaction. J Endourol 2008; 22(11): 2507–2511.

83. Gnessin E, Yossepowitch O, Holland R et al. Holmium laser endoureterotomy for benign ureteral stricture: a single center experience. J Urol 2009; 182(6): 2775–2779.

84. Hibi H, Ohori T, Taki T et al. Long-term results of endoureterotomy using a holmium laser. Int J Urol 2007; 14(9): 872–874.

85. Kourambas J, Delvecchio FC, Preminger GM. Low-power holmium laser for the management of urinary tract calculi, structures, and tumors. J Endourol 2001; 15(5): 529–532.

86. Lane BR, Desai MM, Hegarty NJ et al. Long--term efficacy of holmium laser endoureterotomy for benign ureteral strictures. Urology 2006; 67(5): 894–897.

87. Laven BA, O’Connor RC, Steinberg GD et al. Long-term results of antegrade endoureterotomy using the holmium laser in patients with ureterointestinal strictures. Urology 2001; 58(6): 924–929.

88. Lin CM, Tsai TH, Lin TC et al. Holmium:yttrium-aluminum-garnet laser endoureterotomy for benign ureteral strictures: a singlecentre experience. Acta Chir Belg 2009; 109(6): 746–750.

89. Razdan S, Silberstein IK, Bagley DH. Ureteroscopic endoureterotomy. BJU Int 2005; 95 (Suppl 2): 94–101.

90. Watterson JD, Sofer M, Wollin TA et al. Holmium: YAG laser endoureterotomy for ureterointestinal strictures. J Urol 2002; 167(4): 1692–1695.

91. Biyani CS, Cornford PA, Powell CS. Ureteroscopic endopyelotomy with the holmium:YAG laser. mid-term results. Eur Urol 2000; 38(2): 139–143.

92. Giddens JL, Grasso M. Retrograde ureteroscopic endopyelotomy using the holmium:YAG laser. J Urol 2000; 164(5): 1509–1512.

93. Bulow H, Bulow U, Frohmuller HG. Transurethral laser urethrotomy in man: preliminary report. J Urol 1979; 121(3): 286–287.

94. Becker HC, Miller J, Noske HD et al. Transurethral laser urethrotomy with argon laser: experience with 900 urethrotomies in 450 patients from 1978 to 1993. Urol Int 1995; 55(3): 150–153.

95. Bloiso G, Warner R, Cohen M. Treatment of urethral diseases with neodymium:YAG laser. Urology 1988; 32(2): 106–110.

96. Dogra PN, Ansari MS, Gupta NP et al. Holmium laser corethrough urethrotomy for traumatic obliterative strictures of urethra: initial experience. Urology 2004; 64(2): 232–235

97. Dogra PN, Nabi G. Core-through urethrotomy using the neodymium: YAG laser for obliterative urethral strictures after traumatic urethral disruption and/or distraction defects: long-term outcome. J Urol 2002; 167 (2 Pt 1): 543–546.

98. Dogra PN, Nabi G. Nd-YAG laser core-through urethrotomy in obliterative posttraumatic urethral strictures in children. Pediatr Surg Int 2003; 19(9–10): 652–655.

99. Eltahawy E, Gur U, Virasoro R et al. Management of recurrent anastomotic stenosis following radical prostatectomy using holmium laser and steroid injection. BJU Int 2008; 102(7): 796–798.

100. Faerber GJ, Park JM, Bloom DA. Treatment of pediatric urethral stricture disease with the neodymium:yttrium-aluminum-garnet laser. Urology 1994; 44(2): 264–267.

101. Futao S, Wentong Z, Yan Z et al. Application of endoscopic Ho:YAG laser incision technique treating urethral strictures and urethral atresias in pediatric patients. Pediatr Surg Int 2006; 22(6): 514–518.

102. Guo F, Lu H, Wang G et al. Transurethral 2-mm laser in the treatment of urethral stricture. World J Urol 2010; 28(2): 173–175.

103. Guo FF, Lu H, Wang GJ et al. Efficacy of transurethral 2 microm laser urethrotomy in the treatment of urethral stricture and atresia [in Chinese]. Zhonghua Yi Xue Za Zhi 2008; 88(18): 1270–1272.

104. Gurdal M, Tekin A, Yucebas E et al. Contact neodymium: YAG laser ablation of recurrent urethral strictures using a side-firing fiber. J Endourol 2003; 17(9): 791–794.

105. Hossain AZ, Khan SA, Hossain S et al. Holmium laser urethrotomy for urethral stricture. Bangladesh Med Res Counc Bull 2004; 30(2): 78–80.

106. Kamal BA. The use of the diode laser for treating urethral strictures. BJU Int 2001; 87(9): 831–833.

107. Matsuoka K, Inoue M, Iida S et al. Endoscopic antegrade laser incision in the treatment of urethral stricture. Urology 2002; 60(6): 968–972.

108. Schmidlin F, Oswald M, Iselin C et al. Vaporization of urethral stenosis using the KTP 532 laser [in French]. Ann Urol (Paris) 1997; 31(1): 38–42.

109. Turek PJ, Malloy TR, Cendron M et al. KTP-532 laser ablation of urethral strictures. Urology 1992; 40(4): 330–334.

110. Vicente J, Salvador J, Caffaratti J. Endoscopic urethrotomy versus urethrotomy plus Nd-YAG laser in the treatment of urethral stricture. Eur Urol 1990; 18(3): 166–168.

111. Xiao J, Wu B, Chen LW et al. Holmium laser urethrotomy for male urethral stricture [in Chinese]. Zhonghua Nan Ke Xue 2008; 14(8): 734–736.

112. Patel SR, Haleblian GE. Ureteroscopic management of renal calculi in a pelvic kidney. Med Health R I 2009; 92(10): 342.

113. Weizer AZ, Springhart WP, Ekeruo WO et al. Ureteroscopic management of renal calculi in anomalous kidneys. Urology 2005; 65(2): 265–269.

114. Sun Y, Gao X, Zhou T et al. 70W holmium: yttrium-aluminumgarnet laser in percutaneous nephrolithotomy for staghorn calculi. J Endourol 2009; 23(10): 1687–1691.

115. Elliott DS, Blute ML, Patterson DE et al. Longterm follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 1996; 47(6): 819–825.

116. Gaboardi F, Bozzola A, Dotti E et al. Conservative treatment of upper urinary tract tumors with Nd:YAG laser. J Endourol 1994; 8(1): 37–41.